Nano Delivery System for Atherosclerosis.

J Funct Biomater

Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang 421001, China.

Published: December 2024

Atherosclerosis, a pathological process propelled by inflammatory mediators and lipids, is a principal contributor to cardiovascular disease incidents. Currently, drug therapy, the primary therapeutic strategy for atherosclerosis, faces challenges such as poor stability and significant side effects. The advent of nanomaterials has garnered considerable attention from scientific researchers. Nanoparticles, such as liposomes and polymeric nanoparticles, have been developed for drug delivery in atherosclerosis treatment. This review will focus on how nanoparticles effectively improve drug safety and efficacy, as well as the continuous development and optimization of nanoparticles of the same material and further explore current challenges and future opportunities in this field.

Download full-text PDF

Source
http://dx.doi.org/10.3390/jfb16010002DOI Listing

Publication Analysis

Top Keywords

nano delivery
4
delivery system
4
atherosclerosis
4
system atherosclerosis
4
atherosclerosis atherosclerosis
4
atherosclerosis pathological
4
pathological process
4
process propelled
4
propelled inflammatory
4
inflammatory mediators
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!